1. Introduction {#sec1-nutrients-11-02187}
===============

The prevalence of asthma, one of the most common chronic diseases in children and young adults, has been increasing in the past few decades \[[@B1-nutrients-11-02187],[@B2-nutrients-11-02187]\]. The worldwide prevalence of doctor diagnosed asthma and clinical asthma (treatment for asthma) in adults were 4.3% (ranging from 0.2% in China to 21.0% in Australia) and 4.5% (ranging from 1.0 in Vietnam to 21.5% in Australia), respectively \[[@B3-nutrients-11-02187]\]. In Korea, the prevalence of doctor diagnosed asthma was estimated to be within 0.7% to 2.0% between 1998 to 2008 \[[@B4-nutrients-11-02187]\].

Nutritional epidemiological studies have reported that the dietary intake of fruit \[[@B5-nutrients-11-02187],[@B6-nutrients-11-02187]\], fish \[[@B7-nutrients-11-02187]\], n-3 polyunsaturated fatty acids (PUFA) \[[@B8-nutrients-11-02187],[@B9-nutrients-11-02187]\], n-3/n-6 PUFA \[[@B7-nutrients-11-02187]\], oleic acids \[[@B10-nutrients-11-02187]\], and antioxidant nutrients \[[@B6-nutrients-11-02187],[@B11-nutrients-11-02187]\] may be associated with asthma. Whether the dietary intake of fatty acid and fish can protect against asthma, however, remains controversial. A cross-sectional study found significant inverse associations between fish consumption and the high ratio of n-3/n-6 PUFA with asthma, among Japanese women \[[@B7-nutrients-11-02187]\]. A prospective cohort study (Coronary Artery Risk Development in Young Adults, CARDIA) of young adults in the United States showed that the incidence of asthma in participants in the highest quintile of long-chain n-3 PUFA intake significantly decreased by 54% compared to those in the lowest quintile \[[@B9-nutrients-11-02187]\]. However, the European Prospective Investigation into Cancer and nutrition (EPIC) Heidelberg cohort reported no protective effect of dietary fatty acids intake on asthma \[[@B10-nutrients-11-02187]\]. Additionally, many epidemiological and observational studies showed that maternal intake of fish and fatty acids during pregnancy was associated with asthma in infants or children resulting from those pregnancies \[[@B8-nutrients-11-02187],[@B12-nutrients-11-02187],[@B13-nutrients-11-02187],[@B14-nutrients-11-02187]\].

In the Korean population, few studies have been performed on the associations between asthma and dietary factors, such as Kimchi consumption \[[@B15-nutrients-11-02187]\] and household food insecurity \[[@B16-nutrients-11-02187]\]. However, whether fish and fatty acid consumption is related to the prevalence of asthma has never been studied in Korea.

Therefore, the aim of this study was to identify the association between asthma and diet, including the intake of fish, seaweeds, and fatty acids in Korean adults, using the Korea National Health and Nutrition Examination Survey (KNHANES) data.

2. Methods {#sec2-nutrients-11-02187}
==========

2.1. Study Population {#sec2dot1-nutrients-11-02187}
---------------------

This cross-sectional study used the sixth and seventh KNHANES (2013--2016) data conducted by the Korean Ministry of Health and Welfare. The KNHANES is a nationwide representative data based on stratified sampling design. Detailed information about the survey is available at <http://knhanes.cdc.go.kr>. The study population included men and women (aged 19 to 64 years old) who had completed a health examination and nutrition survey. We excluded a total of 5237 men and women; pregnant women (*n* = 122); prior cancer patients (e.g., liver, stomach, colorectal, uterine or cervical cancer) (*n* = 506); those with missing asthma data (*n* = 2302); those without 24 h dietary recall data (*n* = 2055); those with energy intake of less than 500 kcal/day or more than 5,000 kcal/day (*n* = 252). Thus, a total of 13,038 participants were used in the final analysis ([Figure 1](#nutrients-11-02187-f001){ref-type="fig"}).

2.2. Definition of Asthma {#sec2dot2-nutrients-11-02187}
-------------------------

Asthma was defined as doctor-diagnosed asthma and as medication prescribed asthma. In the health interview survey, the questionnaire contained questions on physician-diagnosed asthma and the medication used for asthma. We used the following questions in this study: "have you ever been diagnosed with asthma by a doctor?" and; "are you currently taking any medicine for asthma?". Doctor-diagnosed asthma was described as the asthma diagnosed by a doctor. The participants were divided into a group without asthma (*n* = 23,723) and a group with asthma (*n* = 315), according to self-reported doctor-diagnosed asthma. Additionally, the participants were further divided into the group without asthma (*n* = 12,905) and the group with asthma (*n* = 133), based on the medication prescribed asthma medications.

2.3. Dietary Assessment {#sec2dot3-nutrients-11-02187}
-----------------------

The dietary intakes of the participants were estimated by the 24-h dietary recall method. In this study, the food items were categorized into eight food groups including cereals/potatoes/sugar products, beans/nuts/seeds, meats and eggs, fishes and shellfishes, milk and dairy products, fruits and vegetable, mushrooms, and seaweeds. Dietary intakes of energy and 10 nutrients such as carbohydrate, protein, fat, calcium, iron, thiamin, riboflavin, niacin, vitamin C, vitamin A were estimated. Dietary fatty acids intakes including saturated fatty acid (SFA), monounsaturated fatty acids (MUFA), polyunsaturated fatty acid (PUFA), omega-3 (n3) fatty acids, omega-6 (n6) fatty acids, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), cholesterol were calculated using 24-h dietary recall data in KNHANES.

2.4. Covariates {#sec2dot4-nutrients-11-02187}
---------------

Characteristics based on socioeconomic status, including age, sex (male and female), BMI (body mass index), residential area (urban and rural), education level (less than high school graduation, high school graduation, college graduate or higher), family income (low, moderately low, moderately high, high), were collected. Lifestyle characteristics including alcohol consumption (never, ≤1 drink/month, 2-4 drink/month, 2-3 drink/week, ≥4 drink/week), dietary supplement use (yes or no) and smoking status (current smokers, ex-smokers, nonsmokers) were collected.

2.5. Statistical Analysis {#sec2dot5-nutrients-11-02187}
-------------------------

The PROC SURVEYFREQ procedure was used to examine differences in categorical variables according to the presence of asthma. The PROC SURVEYMEANS procedure was used to calculate the weighted mean and standard error of continuous variables. Statistical differences in the different asthma groups were analyzed with the PROC SURVEYREG procedure. Multivariate logistic regression was performed to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for asthma across the quartile of fish and shellfish, seaweeds, total fat and fatty acid intake---considering the lowest quartile as the reference. The adjusted variables were age, sex, residential area, household income, education level, smoking status, alcohol consumption, dietary supplement use, body mass index, energy intake, and fruit and vegetable intake. Statistical significance was considered as the data showed *p* \< 0.05. All statistical analyses were performed using the SAS version 9.4 (SAS Institute, Cary, NC, USA).

3. Results {#sec3-nutrients-11-02187}
==========

3.1. Characteristics Based on the Presence of Asthma {#sec3dot1-nutrients-11-02187}
----------------------------------------------------

Characteristics of the study subjects according to the presence of asthma are shown in [Table 1](#nutrients-11-02187-t001){ref-type="table"}. Of the 13,038 eligible subjects, the prevalence of doctor-diagnosed asthma and medication prescribed asthma were 2.5% and 1.0%, respectively. The subjects with doctor-diagnosed asthma were likely to be younger than those without doctor-diagnosed asthma (*p* = 0.0335). However, the subjects with medication prescribed asthma were likely to be older, have higher BMI and have lower education level than those without medication prescribed asthma (*p* \< 0.05). There were no significant differences in residential area, family income, alcohol consumption, dietary supplement use, smoking status in either the doctor-diagnosed asthma or the medication prescribed asthma groups.

3.2. Daily Food and Nutrient Intake Based on the Presence of Asthma {#sec3dot2-nutrients-11-02187}
-------------------------------------------------------------------

Daily intakes of food and nutrients did not differ significantly in the doctor-diagnosed asthma group after adjustments for age, sex, residential area, household income, education level, smoking status, alcohol consumption, dietary supplement use, BMI, and energy intake were made. However, the subjects with doctor-diagnosed asthma (24.7 g/d) tended to consume fewer seaweeds compared to those without doctor-diagnosed asthma (17.4 g/d) (*p* = 0.0638). Interestingly, the subjects with medication-prescribed asthma had a significantly lower consumption of cereals/potatoes/sugar products (*p* = 0.0006) and seaweeds (*p* = 0.0110) than those without medication prescribed asthma. Additionally, in the subjects with medication-prescribed asthma, the mean daily intake of carbohydrate (*p* = 0.0195), iron (*p* = 0.0246), and n3/n6 (*p* = 0.0275) were lower compared to the subjects without medication prescribed asthma ([Table 2](#nutrients-11-02187-t002){ref-type="table"}).

3.3. Association between Dietary Intake and Asthma {#sec3dot3-nutrients-11-02187}
--------------------------------------------------

Adults in the highest quartiles showed significantly decreased prevalence of doctor-diagnosed asthma based on the dietary intake of certain foods. Specifically, we found a 37% reduction for fish \[OR (95% CI) = 0.63 (0.41--0.97), *p* for trend = 0.0637\], intake and a 34% reduction for seaweeds \[OR (95% CI) = 0.66 (0.44--1.00), *p* for trend = 0.0300\] intake, after adjustment for confounding factors. In the subjects with medication-prescribed asthma, there was a significant negative association between seaweeds and medication prescribed asthma \[OR (95% CI) = 0.37 (0.19--0.70), *p* for trend \< 0.0001\] ([Table 3](#nutrients-11-02187-t003){ref-type="table"}).

Multiple logistic regression analysis showed a significant negative association between specific dietary fatty acid and asthma ([Table 4](#nutrients-11-02187-t004){ref-type="table"}). Medication prescribed asthma was inversely associated with n-3 PUFA \[OR (95% CI) = 0.43 (0.21--0.89), *p* for trend = 0.4776\] and n3/n6 \[OR (95% CI) = 0.47 (0.22--0.99), *p* for trend = 0.0563\] intake---after adjusting for confounding factors.

4. Discussion {#sec4-nutrients-11-02187}
=============

In this cross--sectional study from KNHANES (2013--2016), we examined the relationship between asthma and dietary intake of fish, seaweeds, and fatty acids among Korean adults. The subjects with medication prescribed asthma were found to be older, have higher BMI and have lower education level than those without medication--prescribed asthma. For the daily intake of foods and nutrients, the subjects with doctor--diagnosed asthma tended to consume fewer seaweeds than those without doctor-diagnosed asthma. The subjects with medication prescribed asthma had a significantly lower consumption of cereals/potatoes/sugar products and seaweeds than those without medication prescribed asthma. We found a high consumption of fish, seaweeds, n-3 PUFA, and a high ratio of n3/n6 PUFA were inversely associated with the prevalence of asthma.

Asthma is a chronic inflammatory disease that is closely associated with environmental and dietary factors. Recently, there has been growing evidence suggesting that the dietary intake of vitamin C, E, D, and n-3 PUFA play an important role in modulating morbidity caused by asthma and allergic diseases \[[@B17-nutrients-11-02187]\]. Biochemical studies show, that anti-inflammatory precursors such as resolvins, protectins, and maresins are converted from omega-3(n-3) fatty acid, while arachidonic acid (n-6 PUFA)-derived prostaglandins and leukotrienes act as pro-inflammatory mediators \[[@B8-nutrients-11-02187]\]. Since high intake of fish and seafood may help reduce the prevalence of asthma, many epidemiological and clinical studies have evaluated the relationship between asthma and the intake of fish oil---especially n-3 PUFA. Miyamoto et al. \[[@B7-nutrients-11-02187]\] reported that fish consumption and the ratio of n-3/n-6 PUFA, had significant inverse relationships with the prevalence of asthma in Japanese young adults. Similar to our findings, this study reported as well that the ratio of n-3/n-6 PUFA in the highest tertile showed a significant decrease in prevalence of asthma. Another study of the 20-year follow-up longitudinal analysis among American young adults showed as well that intake of long-chain n-3 PUFAs inversely associated with the prevalence of asthma. Several studies examined the relationship between maternal fish intake during pregnancy and the resulting atopy and asthma in children during infancy. These studies reported that fish intake during pregnancy was associated with a protective effect on the incidence of allergic diseases including atopy, eczema, and asthma in early infancy \[[@B18-nutrients-11-02187],[@B19-nutrients-11-02187],[@B20-nutrients-11-02187],[@B21-nutrients-11-02187]\]. A recent systematic review on maternal dietary intake and asthma showed that, offspring of mothers with diets rich in fruits and vegetables, fish, or Mediterranean diets (rich in fruits and vegetables, and low in refined grains and saturated fat) were associated with a lower risk of asthma \[[@B22-nutrients-11-02187],[@B23-nutrients-11-02187]\]. Additionally, several studies reported the beneficial effects of fish intake during childhood, showing decreased rate or prevention of asthma and atopic diseases. The studies of Hodge et al. \[[@B24-nutrients-11-02187]\] and Takemura et al. \[[@B25-nutrients-11-02187]\] reported the inverse association between fish consumption and the prevalence of asthma in children aged between six to 15 years. The recent meta-analysis studying the association between fish intake and risk of childhood asthma found that fish intake in infants was negatively related to the incidence of asthma \[[@B26-nutrients-11-02187]\]. However, other studies have shown inconsistent or negative results of fish and n-3 PUFA intakes on the risk of asthma. Another prospective study from Nagel and Linseisen, did not find any association between the dietary intake of n-3 PUFA, α-linolenic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) and asthma \[[@B10-nutrients-11-02187]\]. Similarly, a study where 60,774 mother-child pairs participated in 18 European and US birth cohort studies negated the beneficial effects of intake of fish and seafood during pregnancy on the risk of allergic diseases including asthma, wheezing, and allergic rhinitis in children up to eight years old \[[@B27-nutrients-11-02187]\]. A case-control study reported that intake of n-3 PUFA did not show any significant differences in the effects between asthmatic and non-asthmatic adults \[[@B28-nutrients-11-02187]\]. Moreover, several birth cohort studies failed to report a protective effect of maternal dietary intake of n-3 PUFA or n-3 in cord blood on asthma risk in childhood \[[@B29-nutrients-11-02187],[@B30-nutrients-11-02187],[@B31-nutrients-11-02187]\].

On the contrary, reports on dietary intake of monounsaturated fatty acids and trans-fatty acids show a positive correlation to the risk of asthma and other allergic diseases \[[@B32-nutrients-11-02187],[@B33-nutrients-11-02187],[@B34-nutrients-11-02187]\]. Dunder et al. \[[@B35-nutrients-11-02187]\] reported as well that children with atopy were positively associated with higher intake of margarine and lower intake of butter than those with non-atopy. Similarly, Nagel and Linseisen \[[@B10-nutrients-11-02187]\] reported as well that high dietary intakes of oleic acid (C18:1) and margarine were positively associated with the risk of asthma in adults. Omega-6 (n-6) PUFAs in margarine and vegetable oil are converted into arachidonic acid, which can produce proinflammatory metabolites such as prostaglandins and leukotrienes \[[@B8-nutrients-11-02187]\]. Therefore, it is still controversial whether the intakes of n-3 PUFAs and fish can reduce the risk of asthma or whether the intake of n-6 PUFAs can increase the risk of asthma.

This study has some limitations. First, the prevalence of asthma could not be confirmed due to the self-administered survey as opposed to standardized measures. Second, we could not assess an accurate causal association between the intake of fish and n-3 PUFAs and the risk of asthma because of the cross-sectional design. Third, we could not calculate the actual intake of fish and n-3 PUFAs from the participants' diet, because we could only collect the one-day 24-h recall data. However, this result can be generalized to the Korean people since a nationwide representative population-based sample of Korean origin was used. Moreover, this result might have an important implication for public health and further studies. Based on this study, further clinical research is required to determine the relationship between asthma and diet with certainty.

5. Conclusions {#sec5-nutrients-11-02187}
==============

There are significantly inverse associations between consumption of fish, seaweeds, and ratio of n3/n6 PUFA and asthma in Korean adults. These results suggest that high consumption of fish, seaweeds, and foods rich in n3 PUFA may provide benefits to asthma. Further studies are needed to confirm the mechanisms related to the beneficial effects of fish and seaweeds and PUFA against asthma.
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nutrients-11-02187-t001_Table 1

###### 

General characteristics of the subjects according to asthma.

  Variables                Doctor-Diagnosed Asthma   Medication-Prescribed Asthma                                             
  ------------------------ ------------------------- ------------------------------ ------------- -------------- ------------ --------
  Sex                                                                                                                         
  Male                     5113 (50.6)               105 (45.1)                     0.1049        5175 (50.5)    43 (45.0)    0.2904
  Female                   7610 (49.4)               210 (54.9)                     7730 (49.5)   90 (55.0)                   
  Age (years)              41.2 ± 0.2                39.2 ± 1.0                     0.0335        41.1 ± 0.2     44.9 ± 1.4   0.0063
  BMI (kg/m^2^)            23.8 ± 0.0                24.1 ± 0.2                     0.1387        23.8 ± 0.0     24.8 ± 0.4   0.0106
  Residential area                                                                                                            
  Urban                    10611 (85.7)              256 (84.2)                     0.4917        10765 (85.7)   102 (81.4)   0.2037
  Rural                    2112 (14.3)               59 (15.8)                      2140 (14.3)   31 (18.6)                   
  Education level                                                                                                             
  \<High school graduate   6170 (43.5)               161 (42.3)                     0.8637        6241 (43.3)    90 (58.0)    0.0185
  High school graduate     2090 (17.7)               51 (19.0)                      2129 (17.8)   12 (11.8)                   
  ≥College graduate        4429 (38.8)               102 (38.7)                     4500 (38.9)   31 (30.1)                   
  Household income                                                                                                            
  Low                      1192 (9.0)                42 (11.2)                      0.1535        1210 (9.0)     24 (15.7)    0.0993
  Moderately low           3142 (24.3)               65 (21.3)                      3176 (24.2)   31 (22.6)                   
  Moderately high          3963 (31.5)               111 (36.4)                     4033 (31.6)   41 (32.2)                   
  High                     4389 (35.3)               97 (31.0)                      4449 (35.2)   37 (29.5)                   
  Alcohol consumption                                                                                                         
  Never                    1786 (13.2)               59 (16.4)                      0.4215        1814 (13.2)    31 (21.5)    0.1548
  ≤1 drink/month           3902 (32.1)               97 (33.2)                      3960 (32.2)   39 (31.0)                   
  2--4 drink/month         3192 (29.3)               69 (28.7)                      3241 (29.3)   20 (21.1)                   
  2--3 drink/week          2032 (18.7)               47 (17.5)                      2060 (18.6)   19 (19.3)                   
  ≥4 drink/week            747 (6.7)                 12 (4.2)                       752 (6.6)     7 (7.1)                     
  Dietary supplement use                                                                                                      
  Yes                      5861 (44.4)               133 (41.1)                     0.2846        5938 (44.3)    56 (40.8)    0.4951
  Smoking status                                                                                                              
  Current smokers          2172 (25.8)               54 (25.0)                      0.6101        2202 (25.8)    24 (29.4)    0.8019
  Ex-smokers               379 (4.4)                 5 (2.9)                        382 (4.4)     2 (3.5)                     
  Nonsmokers               7974 (69.8)               207 (72.0)                                   81 (67.1)                   

Data are n(%) or mean ± SE.

nutrients-11-02187-t002_Table 2

###### 

Daily food and nutrient intakes of the subjects according to asthma.

  Variables                         Doctor-Diagnosed Asthma   Medication-Prescribed Asthma                                           
  --------------------------------- ------------------------- ------------------------------ -------- -------------- --------------- --------
  Food intake (g)                                                                                                                    
  Cereals/potatoes/sugar products   349.3 ± 2.3               333.2 ± 11.3                   0.2961   349.1 ± 2.2    321.7 ± 16.1    0.0006
  Beans/nuts/seeds                  44.0 ± 0.9                38.3 ± 4.1                     0.5653   43.9 ± 0.9     41.5 ± 7.2      0.6520
  Meats and eggs                    146.8 ± 1.9               132.7 ± 10.5                   0.9874   146.6 ± 1.9    127.6 ± 17.5    0.8904
  Fishes and shellfishes            98.2 ± 1.9                83.1 ± 10.2                    0.5890   97.9 ± 1.9     90.0 ± 20.8     0.8761
  Fishes                            27.6 ± 0.7                22.4 ± 3.3                     0.0923   27.5 ± 0.7     27.1 ± 5.8      0.5785
  Milk and dairy products           88.9 ± 1.8                110.2 ± 14.8                   0.2664   89.1 ± 1.8     118.4 ± 29.9    0.3723
  Fruit and vegetable               518.1 ± 4.6               494.5 ± 24.9                   0.8628   517.3 ± 4.6    534.1 ± 39.9    0.9614
  Mushrooms                         6.7 ± 0.3                 4.5 ± 0.8                      0.0964   6.7 ± 0.3      4.9 ± 1.4       0.3942
  Seaweeds                          24.7 ± 1.1                17.4 ± 3.3                     0.0638   24.6 ± 1.1     13.5 ± 4.1      0.0110
  Energy and nutrient intake                                                                                                         
  Energy (kcal)                     2128.8 ± 9.8              2028.3 ± 58.3                  0.0705   2127.0 ± 9.7   2056.5 ± 97.6   0.6463
  Carbohydrate (g)                  312.0 ± 1.4               302.7 ± 8.3                    0.7192   311.8 ± 1.4    302.2 ± 12.7    0.0195
  Protein (g)                       75.2 ± 0.4                71.6 ± 3.0                     0.4817   75.2 ± 0.4     74.3 ± 5.4      0.3215
  Fat (g)                           50.6 ± 0.4                47.6 ± 2.0                     0.7848   50.5 ± 0.4     47.2 ± 3.3      0.3143
  Calcium (mg)                      501.8 ± 3.3               496.7 ± 25.5                   0.4282   501.5 ± 3.3    524.7 ± 46.1    0.5543
  Iron (mg)                         17.7 ± 0.2                16.0 ± 0.6                     0.1972   17.6 ± 0.2     16.1 ± 1.0      0.0246
  Thiamin (mg)                      2.1 ± 0.0                 2.0 ± 0.1                      0.9728   2.1 ± 0.0      2.1 ± 0.1       0.5263
  Riboflavin (mg)                   1.5 ± 0.0                 1.5 ± 0.1                      0.1498   1.5 ± 0.0      1.6 ± 0.2       0.1721
  Niacin (mg)                       17.4 ± 0.1                16.5 ± 0.7                     0.8362   17.4 ± 0.1     17.2 ± 1.4      0.6666
  Vitamin C (mg)                    100.5 ± 1.5               95.6 ± 7.5                     0.8166   100.3 ± 1.5    110.3 ± 13.6    0.8952
  Vitamin A (μgRE)                  751.9 ± 11.1              780.7 ± 75.2                   0.6336   752.1 ± 11.1   798.2 ± 160.8   0.6804
  Fatty acids                                                                                                                        
  SFA (g)                           14.7 ± 0.1                14.3 ± 0.7                     0.3194   14.7 ± 0.1     14.5 ± 1.3      0.1252
  MUFA (g)                          16.2 ± 0.1                15.3 ± 0.8                     0.7624   16.2 ± 0.1     15.4 ± 1.2      0.1925
  PUFA (g)                          12.2 ± 0.1                11.4 ± 0.6                     0.9407   12.2 ± 0.1     11.0 ± 0.8      0.9465
  n-3 (g)                           1.7 ± 0.0                 1.5 ± 0.1                      0.8966   1.7 ± 0.0      1.5 ± 0.1       0.6403
  n-6 (g)                           10.6 ± 0.1                9.8 ± 0.5                      0.9783   10.6 ± 0.1     9.6 ± 0.7       0.8517
  n3/n6                             0.18 ± 0.00               0.17 ± 0.01                    0.0708   0.18 ± 0.00    0.16 ± 0.01     0.0275
  EPA (mg)                          108.2 ± 2.6               96.2 ± 15.7                    0.9384   107.6 ± 2.6    135.9 ± 37.0    0.3860
  DHA (mg)                          187.7 ± 5.2               152.1 ± 22.5                   0.5155   186.6 ± 5.1    205.4 ± 50.5    0.5818
  Cholesterol (mg)                  283.5 ± 2.9               287.6 ± 19.0                   0.4395   283.5 ± 2.8    291.7 ± 31.0    0.3442

Fish: daily fish intake except for salted and fermented seafood, adjusted for age, sex, residential area, education level, household income, alcohol consumption, dietary supplement use, smoking status, body mass index, and energy intake.

nutrients-11-02187-t003_Table 3

###### 

Association between fish and seaweeds intake and asthma.

  Variable             Range (g)       Median (g)   Doctor-Diagnosed Asthma   Medication-Prescribed Asthma                                                            
  -------------------- --------------- ------------ ------------------------- ------------------------------ ------------------- ---------------- ------------------- -------------------
  Fish and shellfish                                                                                                                                                  
  Q1                   \<4.07          0            94/3259 (2.88)            1                              1                   41/3259 (1.26)   1                   1
  Q2                   4.07--35.20     14.82        78/3260 (2.39)            0.82 (0.60--1.13)              0.90 (0.62--1.32)   32/3260 (0.98)   0.71 (0.42--1.20)   0.77 (0.41--1.44)
  Q3                   35.21--125.14   67.05        71/3260 (2.18)            0.82 (0.58--1.17)              0.75 (0.49--1.15)   35/3260 (1.07)   0.93 (0.56--1.55)   0.71 (0.38--1.34)
  Q4                   \>125.14        233.34       72/3259 (2.21)            0.77 (0.54--1.10)              0.85 (0.57--1.27)   25/3259 (0.77)   0.55 (0.31--0.98)   0.57 (0.29--1.12)
  *P* for trend                                                               0.2705                         0.6894                               0.0501              0.1005
  Fish                                                                                                                                                                
  Q1                   0               0            135/4782 (2.82)           1                              1                   51/4782 (1.07)   1                   1
  Q2                   \<2.49          1.09         43/1737 (2.48)            0.73 (0.49--1.11)              0.78 (0.49--1.24)   17/1737 (0.98)   0.78 (0.42--1.43)   0.80 (0.38--1.69)
  Q3                   2.49--24.01     7.46         74/3260 (2.27)            0.65 (0.47--0.91)              0.71 (0.48--1.04)   36/3260 (1.10)   0.71 (0.45--1.12)   0.60 (0.34--1.07)
  Q4                   \>24.01         69.32        63/3259 (1.93)            0.71 (0.51--0.99)              0.63 (0.41--0.97)   29/3259 (0.89)   0.91 (0.54--1.53)   0.77 (0.40--1.50)
  *P* for trend                                                               0.1617                         0.0637                               0.9453              0.6532
  Seaweeds                                                                                                                                                            
  Q1                   0               0            141/5627 (2.51)           1                              1                   62/5627 (1.10)   1                   1
  Q2                   \<1.00          0.50         27/896 (3.01)             0.82 (0.50--1.34)              0.78 (0.43--1.40)   10/896 (1.12)    0.84 (0.38--1.84)   0.82 (0.30--2.24)
  Q3                   1.01--7.47      3.07         75/3256 (2.30)            0.87 (0.64--1.19)              0.95 (0.66--1.36)   34/3256 (1.04)   0.88 (0.56--1.41)   0.99 (0.57--1.75)
  Q4                   \>7.47          28.84        72/3259 (2.21)            0.72 (0.53--0.98)              0.66 (0.44--1.00)   27/3259 (0.83)   0.52 (0.32--0.85)   0.37 (0.19--0.70)
  *P* for trend                                                               0.0346                         0.0300                               0.0018              \<0.0001

Doctor-diagnosed asthma: self-reported doctor diagnosis of asthma. Medication prescribed asthma: prescribed oral and inhaled asthma medications in the past 12 months. Fish: daily fish intake except for salted and fermented seafood. Adjusted for age, sex, residential area, education level, household income, alcohol consumption, dietary supplement use, smoking status, body mass index, energy intake and fruit and vegetable intake.
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###### 

Association between specific types of dietary fat and asthma.

  Variable        Range (g)        Median (g)   Doctor-Diagnosed Asthma   Medication-Prescribed Asthma                                                            
  --------------- ---------------- ------------ ------------------------- ------------------------------ ------------------- ---------------- ------------------- -------------------
  Total fat                                                                                                                                                       
  Q1              \<24.52          16.94        89/3259 (2.73)            1                              1                   42/3259 (1.29)   1                   1
  Q2              24.52--39.69     32.00        73/3260 (2.24)            0.79 (0.55--1.14)              0.75 (0.48--1.17)   32/3260 (0.98)   0.78 (0.46--1.32)   0.76 (0.38--1.50)
  Q3              39.70--60.98     48.90        83/3260 (2.55)            0.90 (0.64--1.26)              0.92 (0.59--1.43)   31/3260 (0.95)   0.74 (0.47--1.17)   0.96 (0.48--1.93)
  Q4              \>60.98          83.53        70/3259 (2.15)            0.80 (0.55--1.16)              1.04 (0.60--1.81)   28/3259 (0.86)   0.75 (0.44--1.27)   1.61 (0.65--3.99)
  *P* for trend                                                           0.3792                         0.6269                               0.3702              0.2090
  SFA                                                                                                                                                             
  Q1              \<6.36           4.21         783259 (2.39)             1                              1                   41/3259 (1.26)   1                   1
  Q2              6.36--11.02      8.67         82/3260 (2.52)            1.18 (0.82--1.69)              1.21 (0.78--1.89)   26/3260 (0.80)   0.67 (0.38-1.20)    0.59 (0.83-1.15)
  Q3              11.03-17.73      13.96        77/3260 (2.36)            1.15 (0.80-1.65)               1.33 (0.84-2.11)    38/3260 (1.17)   1.05 (0.66-1.68)    1.59 (0.83-3.08)
  Q4              \>17.73          25.05        78/3259 (2.39)            1.11 (0.77-1.60)               1.63 (0.97-2.73)    28/3259 (0.86)   0.80 (0.46-1.37)    1.58 (0.74-3.38)
  *P* for trend                                                           0.7875                         0.0743                               0.7171              0.0871
  MUFA                                                                                                                                                            
  Q1              \<6.90           4.55         87/3259 (2.67)            1                              1                   42/3259 (1.29)   1                   1
  Q2              6.90-12.04       9.48         79/3260 (2.42)            0.98 (0.68-1.39)               0.99 (0.63-1.55)    31/3260 (0.95)   0.89 (0.52-1.50)    1.14 (0.57-2.27)
  Q3              12.05--19.76     15.24        78/3260 (2.39)            0.91 (0.63--1.32)              0.87 (0.54--1.40)   31/3260 (0.95)   0.75 (0.46--1.23)   0.92 (0.41--2.08)
  Q4              \>19.76          27.87        71/3259 (2.18)            0.87 (0.60--1.26)              1.05 (0.57--1.93)   29/3259 (0.89)   0.84 (0.50--1.43)   1.77 (0.66--4.76)
  *P* for trend                                                           0.4361                         0.8685                               0.5791              0.2505
  PUFA                                                                                                                                                            
  Q1              \<5.57           3.76         95/3259 (2.92)            1                              1                   48/3259 (1.47)   1                   1
  Q2              5.57--9.24       7.36         64/3260 (1.96)            0.67 (0.46--0.97)              0.72 (0.45--1.16)   27/3260 (0.83)   0.56 (0.33--0.94)   0.58 (0.28--1.18)
  Q3              9.25--14.92      11.71        87/3260 (2.67)            1.04 (0.74--1.46)              1.09 (0.70--1.69)   30/3260 (0.92)   0.85 (0.52--1.40)   0.86 (0.42--1.75)
  Q4              \>14.92          21.0         69/3259 (2.12)            0.74 (0.51--1.07)              1.10 (0.66--1.84)   28/3259 (0.86)   0.55 (0.33--0.93)   0.85 (0.37--1.99)
  *P* for trend                                                           0.3328                         0.3753                               0.0803              0.9308
  n--3 PUFA                                                                                                                                                       
  Q1              \<0.65           0.41         91/3259 (2.79)            1                              1                   49/3259 (1.50)   1                   1
  Q2              0.65--1.19       0.90         77/3260 (2.36)            0.82 (0.58--1.16)              0.86 (0.57--1.29)   28/3260 (0.86)   0.55 (0.32--0.93)   0.62 (0.31--1.22)
  Q3              1.20--2.10       1.56         81/3260 (2.48)            0.80 (0.56--1.14)              0.82 (0.53--1.26)   27/3260 (0.83)   0.47 (0.27--0.82)   0.43 (0.21--0.89)
  Q4              \>2.10           3.07         66/3259 (2.03)            0.74 (0.51--1.10)              0.90 (0.57--1.40)   29/3259 (0.89)   0.63 (0.37--1.07)   0.71 (0.33--1.51)
  *P* for trend                                                           0.1918                         0.7609                               0.2290              0.4776
  n--6 PUFA                                                                                                                                                       
  Q1              \<4.65           3.09         93/3259 (2.85)            1                              1                   48/3259 (1.47)   1                   1
  Q2              4.65--7.85       6.24         72/3260 (2.21)            0.82 (0.56--1.19)              0.92 (0.58--1.45)   28/3260 (0.86)   0.64 (0.38--1.09)   0.69 (0.35--1.36)
  Q3              7.86--12.93      10.04        81/3260 (2.48)            0.99 (0.70--1.41)              1.03 (0.65--1.63)   29/3260 (0.89)   0.79 (0.47--1.31)   0.82 (0.38--1.74)
  Q4              \>12.93          18.30        69/3259 (2.12)            0.75 (0.52--1.09)              1.07 (0.63--1.82)   28/3259 (0.86)   0.54 (0.32--0.89)   0.80 (0.32--1.98)
  *P* for trend                                                           0.2015                         0.6872                               0.0305              0.7295
  n--3/n--6                                                                                                                                                       
  Q1              \<0.10           0.08         92/3259 (2.82)            1                              1                   45/3259 (1.38)   1                   1
  Q2              0.10--0.13       0.12         68/3259 (2.09)            0.78 (0.54--1.15)              0.92 (0.59--1.43)   29/3259 (0.89)   0.60 (0.35--1.02)   0.61 (0.32--1.16)
  Q3              0.14--0.19       0.16         75/3260 (2.30)            0.89 (0.63--1.27)              1.01 (0.66--1.58)   33/3260 (1.01)   0.75 (0.45--1.25)   0.69 (0.36--1.31)
  Q4              \>0.19           0.30         80/3259 (2.45)            0.92 (0.65--1.30)              0.91 (0.58--1.43)   26/3259 (0.80)   0.59 (0.33--1.06)   0.47 (0.22--0.99)
  *P* for trend                                                           0.9761                         0.7471                               0.1475              0.0563
  Cholesterol                                                                                                                                                     
  Q1              \<93.07          48.68        97/3259 (2.98)            1                              1                   45/3259 (1.38)   1                   1
  Q2              93.07--202.34    142.84       62/3260 (1.90)            0.61 (0.42--0.90)              0.64 (0.41--0.99)   33/3260 (1.01)   0.76 (0.48--1.19)   0.84 (0.48--1.49)
  Q3              202.35--361.02   272.54       81/3260 (2.48)            0.86 (0.61--1.21)              1.05 (0.73--1.51)   27/3260 (0.83)   0.60 (0.35--1.04)   0.72 (0.37--1.42)
  Q4              \>361.02         534.53       75/3259 (2.30)            0.87 (0.61--1.24)              0.85 (0.56--1.31)   28/3259 (0.86)   0.88 (0.53--1.46)   0.96 (0.50--1.85)
  *P* for trend                                                           0.9132                         0.9354                               0.8583              0.9555

Doctor--diagnosed asthma: self--reported doctor diagnosis of asthma. Medication prescribed asthma: prescribed oral and inhaled asthma medications in the past 12 months. Adjusted for age, sex, residential area, education level, household income, alcohol consumption, dietary supplement use, smoking status, body mass index, energy intake and fruit and vegetable intake.
